Old drug gets new look as last hope for tough head & neck cancers
NCT ID NCT02369458
Summary
This study tested whether an older chemotherapy drug called mitomycin C could help control advanced head and neck cancer that had grown despite all standard treatments. It involved 48 adults whose cancer had spread or returned and was no longer responding to common therapies. The goal was to see if this drug could shrink tumors or slow the cancer's growth in these difficult-to-treat cases.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SQUAMOUS CELL CARCINOMA OF THE HEAD AND NECK are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Washington University School of Medicine
St Louis, Missouri, 63110, United States
Conditions
Explore the condition pages connected to this study.